Steroid Injections for Joint Pain: When to Give Them and When to Wait

Overuse will definitely damage the kidneys, and can even cause kidney shock with permanent damage. There is also a real risk that commercial protein products are contaminated with anabolic steroids. Gym users should consult a nutritionist or dietitian to be guided on protein source and dose relative to body weight and activity level, rather than following generic online advice.

No, there is no age limit — it can be given from young patients up to the 60s or 70s without a problem. The only practical consideration is the blood volume required: around 14 to 15 ml for PRP and 10 ml for GFC.

No. Steroid is given for active pain and inflammation, early in the treatment pathway. Regenerative therapies like PRP are used once the condition is confirmed chronic with no active inflammation. Combining them is counterproductive, since steroid's anti-inflammatory effect can work against the regenerative signal from the growth factors.

First rule out diabetes and thyroid disease, which account for around 30% of bilateral shoulder presentations in practice, then check for manual/overhead work. If negative, get a plain X-ray to rule out joint space narrowing and calcific tendinopathy, then trial physiotherapy (ultrasonic therapy, TENS, shoulder exercises) with a 3-week NSAID course. In this case, rheumatoid factor came back positive with MRI showing bilateral partial-thickness supraspinatus tears and subacromial bursitis — so the approach became NSAIDs, DMARDs for the underlying rheumatoid disease, a triamcinolone injection into the subacromial bursa, and physiotherapy. A repeat steroid injection should not be given before 3 months. If there is still no response, proceed to shoulder arthroscopy to debride the bursa, assess the AC joint and address the tendon tears directly.

Yes. Chronicity is labelled at 3 months, with 6 to 12 weeks as the clinical boundary. A patient should start with NSAIDs, not regenerative therapy. Only if steroid injection has also failed to control the inflammation between 6 and 12 weeks should regenerative therapy be considered, and 3 months is the ideal timing.

Dr. Mahajan has shifted to using triamcinolone predominantly across joint sizes, after research from the last two to three years showed it works as well in larger joints as methylprednisolone, which he previously reserved for the knee and shoulder.

Not in the first three weeks, when conservative treatment alone is used. If pain is increasing without response by three to six weeks, a steroid injection is added.

The condition is labelled chronic and steroid is no longer the primary tool; the conversation shifts to regenerative therapy instead.

Not within three months of the last injection.